Duligotumab

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Duligotumab
Monoclonal antibody
Type Whole antibody
Source Human
Target HER3
Clinical data
ATC code none
Identifiers
CAS Number 1314238-96-4
ChemSpider none

Duligotumab (INN) is a human monoclonal antibody designed for the treatment of cancer. It acts as an immunomodulator and binds to HER3.[1]

References[edit]

  1. ^ World Health Organization (2012). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 107" (PDF). WHO Drug Information. 26 (2).